Abstract
The comparison of the therapeutic effects of three molecules belonging to the substituted benzamide family allows the following observations: --the three products are generally well tolerated by the organism; --at sufficient doses they act as a major tranquilizers: -sulpiride is chiefly a disinhibitor but also has antipsychotic properties; -sultopride is at first somewhat sedative, especially when given parenterally, then antipsychotic, and little by little desinhibiting; -GRI 16-65 is "soothing", "euphoriant", "sociabilizing", as well as antipsychotic. Effect of reintegration in reality seems to constitute a common characteristic of these three products.
摘要
相似文献
1
[Substituted benzamides].
Encephale. 1975;1(3):223-5.
2
[A new substituted benzamide with neuroleptic effects: lin 14 18 or sultopride].
Encephale. 1975;1(1):15-8.
3
[Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
Ann Med Psychol (Paris). 1985 Jul;143(7):677-82.
4
[Sultopride: a new powerful neuroleptic (author's transl)].
Sem Hop. 1979;55(1-2):63-7.
5
[Situation of sultopride among present-day neuroleptics].
Encephale. 1975;1(1):19-24.
6
Clinical trials of benzamides in psychiatry.
Adv Biochem Psychopharmacol. 1982;35:163-94.
7
[Comparative trials on sultopride and fluanisone].
Encephale. 1978;4(2):145-161.
8
Consensus on the use of substituted benzamides in psychiatric patients.关于在精神科患者中使用取代苯甲酰胺的共识。
Neuropsychobiology. 2004;50(2):134-43. doi: 10.1159/000079104.
9
The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia.取代苯甲酰胺及其在恶劣心境障碍和精神分裂症阴性症状方面的临床潜力。
Mol Psychiatry. 2002;7(3):247-53. doi: 10.1038/sj.mp.4001040.
10
[Trial therapy of psychomotor disorder with a new neuroleptic, sultopride].
Brux Med. 1979 May;59(5):275-7.
Zotero 插件